Description
Semaglutide Peptide For Sale — Research Grade
Semaglutide is a GLP-1 receptor agonist with 94% sequence homology to native GLP-1. Originally developed for type 2 diabetes management, it is now a foundational reference compound in metabolic and incretin biology research, providing a well-characterized pharmacological baseline for comparison with next-generation GLP-1 class peptides.
Research Background
Research on semaglutide has documented its effects on appetite regulation, gastric emptying, insulin secretion, and body weight. It serves as the primary comparator compound in studies of dual agonists (tirzepatide) and triple agonists (retatrutide). Its extensive published pharmacological profile makes it an essential reference tool in metabolic peptide research programs.
Product Specifications
- Compound: Semaglutide
- Purity: ≥99% (HPLC verified)
- Form: Lyophilized powder
- Testing: Third-party Certificate of Analysis available
- Storage: -20°C lyophilized; 4°C after reconstitution, use within 28 days
- For laboratory and research use only — not for human consumption
For research and laboratory use only. Not intended for human consumption. Not for use as a pharmaceutical or clinical therapy.






